Previous 10 | Next 10 |
What You Need to Know About Buying Penny Stocks Today With another day of trading penny stocks here, there is a lot for investors to consider. After an interesting day in the stock market yesterday, investors are eager to see some bullish price action return into trading today. With p...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re gearing up for another busy day of trading with a breakdown of the biggest pre-market stock movers for Thursday! Source: f11photo/Shutterstock.com We’ve got plenty of earnings reports and other n...
Shares of Statera Biopharma (NASDAQ:STAB) soared 53% in aftermarket trading on Wednesday, after the company said it would sell its rights to naltrexone and met-enkephalin to Immune Therapeutics (OTCPK:IMUN). As per the deal, Statera will get an initial $2M upfront payment and 5% of ...
FORT COLLINS, Colo., April 27, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB) (the “Company”), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today that the Company entere...
Statera Biopharma (NASDAQ:STAB) receives Nasdaq notice as it has not yet filed its annual report for the fiscal year ended December 31, 2021. As of March 31, 2022, company was unable to file its Form 10-K within the prescribed time period due to a delay in completing its financial statem...
FORT COLLINS, Colo., April 22, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced the Company received a letter f...
The clinical-stage biotech, Checkmate Pharmaceuticals (NASDAQ:CMPI), has risen more than fourfold in value on Tuesday following its $250 million all-cash deal to be acquired by Regeneron (REGN). The announcement has propelled the developers of Toll-like receptor 9 (TLR9) agonists, a drug clas...
FORT COLLINS, Colo., April 13, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma (Nasdaq: STAB) (the “Company”), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, announced today that the Company has agreed to ...
Penny stocks are a great way to make quick money, but they aren’t for the faint of heart. Whether it’s something to do with global headlines or company-specific catalysts, there are countless ways to make money with penny stocks . Knowing how to trade them and use data...
Coeptis Therapeutics Announces Intent to Acquire TLR5 Agonist Platform, Including Clinical-Stage Asset Entolimod, from Statera Biopharma PR Newswire Entolimod is currently in clinical development as a potential treatment for acute radiation syndrome with additional pre...
News, Short Squeeze, Breakout and More Instantly...
Statera Biopharma Inc. Company Name:
STAB Stock Symbol:
NASDAQ Market:
Statera Biopharma Inc. Website:
Williams Industrial Services Group Inc. (WLMSQ) is expected to report $-0.15 for Q3 2023 Cellcom Israel Limited (CELJF) is expected to report for quarter end 2023-09-30 Central Japan Railway Co ADR (CJPRY) is expected to report for Q2 2024 CW Petroleum Corp (CWPE) is expected to repor...
Strategic Environmental & Energy Resources Inc (SENR) is expected to report for Q1 2024 Biocept Inc. (BIOCQ) is expected to report for Q1 2024 Kalera Public Limited Company (KALRQ) is expected to report for quarter end 2023-09-30 Lanvin Group Holdings Limited (LANV) is expected to...
Murata Manufacturing Co. Ltd. ADR (MRAAY) is expected to report $0.27 for Q2 2024 Quotient Limited (QTNTQ) is expected to report for quarter end 2023-09-30 Evaxion Biotech A/S (EVAX) is expected to report for Q3 2023 American Virtual Cloud Technologies Inc. (AVCTQ) is expected to repo...